Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2705 per EA under NDC 68462043318. Its NADAC has been published 415 times since Jul 18, 2018.
Strength
625 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462043318
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203480On Market Since
5/18/2018
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 415 times since Jul 18, 2018, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2705 per EA |
|---|---|
| All-time high | $2.1506 (Aug 15, 2018) |
| All-time low | $0.1763 (Jul 17, 2024) |
| 52-week high | $0.3117 |
| 52-week low | $0.2660 |
| Median price | $0.4108 |
| Average price | $0.5842 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 415 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2705 per EA (NDC 68462043318), effective Jun 24, 2026.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 87.4%. It has been tracked across 415 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since Jul 18, 2018, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $2.1506 (Aug 15, 2018), with a median of $0.4108 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as COLESEVELAM 625 MG TABLET, but none are currently priced below it.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 68462043318) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification